1.
Anthropic signed compute contracts worth up to $517 billion over eleven months, though it still trailed OpenAI's $750 billion plan through 2030.
2.
Insilico Medicine's AI-designed drug rentosertib appeared to reverse markers of biological aging in an early Nature Biotechnology trial, with six independent aging clocks predicting treated patients were biologically up to six years younger than placebo.
3.
New York City banned AI tools from public schools through eighth grade.
4.
OpenAI reported that AI agents in its research workflows had performed the equivalent of 3.1 human workdays per human workday and said it had reached its goal of an "automated research intern," while its chief scientist warned that alignment and monitoring were inadequate for unchecked scaling.
5.
GPT-6 Astra completed the puzzle game Portal from start to finish without human assistance in about 24 hours, and the developer published the code and documentation on GitHub.


























































































